PMID- 16547927
OWN - NLM
STAT- MEDLINE
DCOM- 20060628
LR  - 20101118
IS  - 1522-1946 (Print)
IS  - 1522-1946 (Linking)
VI  - 67
IP  - 4
DP  - 2006 Apr
TI  - Percutaneous coronary intervention of or through saphenous vein grafts or 
      internal mammary arteries: the impact of stents, adjunctive pharmacology, and 
      multicomponent distal protection.
PG  - 571-9
AB  - We hypothesized that the use of stents and aggressive adjunctive 
      pharmacotherapies has been associated with lower rates of complicating myocardial 
      infarction (MI) and improved long-term outcomes compared to either previous 
      balloon-only percutaneous coronary intervention (PCI) or atheroablative 
      intervention for lesions of or through saphenous vein grafts (SVGs) and/or 
      internal mammary arteries (IMAs). PCI of SVG has been complicated by relatively 
      high rates of procedural MI and less favorable long-term outcomes than native 
      vessel PCI, stimulating the development and application of an array of 
      technologies. This study was based on retrospective review of stent-era 
      (1999-2004) 5-year experience of a single center with 95 SVG procedures in 85 
      patients and 20 IMA procedures in 20 patients. These cases were compared with the 
      previously published experience of one of the operators during the balloon-only 
      period and literature review of the application of multiple technologies to SVG 
      intervention, as well as consideration of the reoperation alternative. There was 
      one in-hospital death each in the SVG cohort (1%) and in the IMA cohort (5%). 
      There were SIX procedural MIs (6%), defined by total CK > normal, and 19 
      procedural MIs (20%) based on troponin-I > 1.0. Follow-up has been from 4 months 
      to 5 years (average, 2.5 years), with 91% survival and one late CABG in the IMA 
      group. SVG PCI with stents and adjunctive pharmacotherapies is associated with 
      relatively low rates of procedural MI and favorable long-term outcomes.
FAU - Morrison, Douglass A
AU  - Morrison DA
AD  - Section of Cardiology, Department of Internal Medicine, SAVAHCS, and the 
      University of Arizona, Sarver Heart Center, Tucson, 85723, USA. 
      douglass.morrison@med.va.gov
FAU - Thai, Hoang
AU  - Thai H
FAU - Goldman, Steven
AU  - Goldman S
FAU - Felix, Edward
AU  - Felix E
FAU - Hernandez, Joseph
AU  - Hernandez J
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Catheter Cardiovasc Interv
JT  - Catheterization and cardiovascular interventions : official journal of the 
      Society for Cardiac Angiography & Interventions
JID - 100884139
RN  - 0 (Platelet Aggregation Inhibitors)
SB  - IM
MH  - Aged
MH  - Angioplasty, Balloon, Coronary/adverse effects/instrumentation/*methods
MH  - Coronary Artery Bypass
MH  - Coronary Artery Disease/*surgery
MH  - Embolism/etiology/prevention & control
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Mammary Arteries/*surgery
MH  - Middle Aged
MH  - Myocardial Infarction/etiology/prevention & control
MH  - Platelet Aggregation Inhibitors/*therapeutic use
MH  - Reoperation
MH  - Retrospective Studies
MH  - Saphenous Vein/*surgery
MH  - *Stents
MH  - Treatment Outcome
EDAT- 2006/03/21 09:00
MHDA- 2006/06/29 09:00
CRDT- 2006/03/21 09:00
PHST- 2006/03/21 09:00 [pubmed]
PHST- 2006/06/29 09:00 [medline]
PHST- 2006/03/21 09:00 [entrez]
AID - 10.1002/ccd.20641 [doi]
PST - ppublish
SO  - Catheter Cardiovasc Interv. 2006 Apr;67(4):571-9. doi: 10.1002/ccd.20641.